Medicine
Caprelsa 300 mg tablet
Caprelsa 300 mg tablet is a prescription medicine containing Vandetanib for oral use, marketed by Genzyme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
CAPRELSA tablets should be stored at room temperature between 68°F and 77°F…
Key facts
- Active ingredient (INN)
- Vandetanib
- Brand
- Caprelsa
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Genzyme
- Manufacturer
- Genzyme
- Origin register
- US FDA, United States
- Storage
- CAPRELSA tablets should be stored at room temperature between 68°F and 77°F (20°C and 25°C), excursions permitted to 59°F–86°F (15°C-30°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XE12 Vandetanib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 July 2011
- Identifiers
- DailyMed set ID e5721cb8-4185-47b9-bbb3-1c587e558a03NDC 58468-7840Application NDA022405
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, plastic in 1 carton / 30 tablet, film coated in 1 bottle, plastic | 58468-7840-3 | Genzyme | 25 July 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Vandetanib
Clinical summary
Vandetanib is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. It is available as tablets for oral use. MedsAcross supplies Vandetanib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VandetanibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CAPRELSA prescribing information (Genzyme) · U.S. National Library of Medicine, DailyMed
- Caprelsa: European public assessment report (EPAR) · European Medicines Agency
Need Caprelsa 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.